Literature DB >> 21610198

Endotoxin-induced uveitis is primarily dependent on radiation-resistant cells and on MyD88 but not TRIF.

J Kezic1, S Taylor, S Gupta, S R Planck, H L Rosenzweig, J T Rosenbaum.   

Abstract

TLR4 activation by LPS (endotoxin) is mediated by the MyD88 and TRIF intracellular signaling pathways. We determined the relative activation of these pathways in murine ocular tissue after LPS exposure. Additionally, we explored whether BM-derived or non-BM-derived cells were the major contributors to EIU. Mice deficient in TRIF or MyD88 and their congenic (WT) controls received 250 ng ultrapure LPS ivt at 0 h. Ocular inflammation was assessed by histological analysis at 4, 6, and 24 h, and additionally, in MyD88(-/-) mice, intravital microscopy was performed at 4 h and 6 h to assess adherent, rolling, and infiltrating cells in the iris vasculature and tissue. Cytokines associated with the MyD88 and TRIF intracellular signaling pathways were analyzed in ocular tissue at 4 h. BM chimeric mice (WT→WT, TLR4(-/-)→WT, WT→TLR4(-/-)) received 250 ng LPS by ivt injection, and ocular tissues were examined by histology at 6 h. Lack of MyD88 resulted in a markedly diminished cellular response and reduced production of MyD88-related cytokines 4 h post-LPS treatment. In contrast, lack of TRIF led to reduced production of TRIF-related cytokines and no change in the cellular response to LPS. Therefore, the MyD88 pathway appears to be the dominant TLR4 pathway in EIU. Only WT → TLR4(-/-) chimeric mice were resistant to EIU, and this suggests, surprisingly, that non-BM-derived (radiation-resistant) cells in the eye play a greater role than BM-derived cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21610198      PMCID: PMC3133435          DOI: 10.1189/jlb.0111036

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  34 in total

1.  De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases.

Authors:  Ivona Aksentijevich; Miroslawa Nowak; Mustapha Mallah; Jae Jin Chae; Wendy T Watford; Sigrun R Hofmann; Leonard Stein; Ricardo Russo; Donald Goldsmith; Peter Dent; Helene F Rosenberg; Frances Austin; Elaine F Remmers; James E Balow; Sergio Rosenzweig; Hirsh Komarow; Nitza G Shoham; Geryl Wood; Janet Jones; Nadira Mangra; Hector Carrero; Barbara S Adams; Terry L Moore; Kenneth Schikler; Hal Hoffman; Daniel J Lovell; Robert Lipnick; Karyl Barron; John J O'Shea; Daniel L Kastner; Raphaela Goldbach-Mansky
Journal:  Arthritis Rheum       Date:  2002-12

2.  MCP-1 expression in endotoxin-induced uveitis.

Authors:  Nadine Tuaillon; De Fen Shen; Ravi B Berger; Bao Lu; Barrett J Rollins; Chi-Chao Chan
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-05       Impact factor: 4.799

3.  Digital video-imaging of leukocyte migration in the iris: intravital microscopy in a physiological model during the onset of endotoxin-induced uveitis.

Authors:  M D Becker; R Nobiling; S R Planck; J T Rosenbaum
Journal:  J Immunol Methods       Date:  2000-06-23       Impact factor: 2.303

4.  Bone marrow chimeras and c-fms conditional ablation (Mafia) mice reveal an essential role for resident myeloid cells in lipopolysaccharide/TLR4-induced corneal inflammation.

Authors:  Holly R Chinnery; Eric C Carlson; Yan Sun; Michelle Lin; Sandra H Burnett; Victor L Perez; Paul G McMenamin; Eric Pearlman
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

5.  NOD2, the gene responsible for familial granulomatous uveitis, in a mouse model of uveitis.

Authors:  Holly L Rosenzweig; Tammy M Martin; Monica M Jann; Stephen R Planck; Michael P Davey; Koichi Kobayashi; Richard A Flavell; James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

6.  Nucleotide oligomerization domain-2 (NOD2)-induced uveitis: dependence on IFN-gamma.

Authors:  Holly L Rosenzweig; Tatsushi Kawaguchi; Tammy M Martin; Stephen R Planck; Michael P Davey; James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-20       Impact factor: 4.799

7.  Differential turnover rates of monocyte-derived cells in varied ocular tissue microenvironments.

Authors:  Jelena Kezic; Paul G McMenamin
Journal:  J Leukoc Biol       Date:  2008-06-24       Impact factor: 4.962

Review 8.  The toll of too much TLR7.

Authors:  Arthur M Krieg
Journal:  Immunity       Date:  2007-11       Impact factor: 31.745

9.  Activation of NOD2 in vivo induces IL-1beta production in the eye via caspase-1 but results in ocular inflammation independently of IL-1 signaling.

Authors:  H L Rosenzweig; T M Martin; S R Planck; K Galster; M M Jann; M P Davey; K Kobayashi; R A Flavell; J T Rosenbaum
Journal:  J Leukoc Biol       Date:  2008-05-21       Impact factor: 4.962

10.  Turnover of bone marrow-derived cells in the irradiated mouse cornea.

Authors:  Holly R Chinnery; Timothy Humphries; Adam Clare; Ariane E Dixon; Kristen Howes; Caitlin B Moran; Danielle Scott; Marianna Zakrzewski; Eric Pearlman; Paul G McMenamin
Journal:  Immunology       Date:  2008-06-06       Impact factor: 7.397

View more
  13 in total

1.  Investigation of the differential potentials of TLR agonists to elicit uveitis in mice.

Authors:  Jordan J Allensworth; Stephen R Planck; James T Rosenbaum; Holly L Rosenzweig
Journal:  J Leukoc Biol       Date:  2011-09-20       Impact factor: 4.962

Review 2.  Interplay between innate and adaptive immunity in the development of non-infectious uveitis.

Authors:  François Willermain; James T Rosenbaum; Bahram Bodaghi; Holly L Rosenzweig; Sarah Childers; Travis Behrend; Gerhild Wildner; Andrew D Dick
Journal:  Prog Retin Eye Res       Date:  2011-11-22       Impact factor: 21.198

3.  Impact of IL-1 signalling on experimental uveitis and arthritis.

Authors:  Stephen R Planck; April Woods; Jenna S Clowers; Martin J Nicklin; James T Rosenbaum; Holly L Rosenzweig
Journal:  Ann Rheum Dis       Date:  2012-01-20       Impact factor: 19.103

4.  Why HLA-B27? My thirty-year quest: the Friedenwald lecture.

Authors:  James T Rosenbaum
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-29       Impact factor: 4.799

5.  Caveolin-1 increases proinflammatory chemoattractants and blood-retinal barrier breakdown but decreases leukocyte recruitment in inflammation.

Authors:  Xiaoman Li; Xiaowu Gu; Timothy M Boyce; Min Zheng; Alaina M Reagan; Hui Qi; Nawajes Mandal; Alex W Cohen; Michelle C Callegan; Daniel J J Carr; Michael H Elliott
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-26       Impact factor: 4.799

6.  TLR9 bone marrow chimeric mice define a role for cerebral TNF in neuroprotection induced by CpG preconditioning.

Authors:  Amy E B Packard; Philberta Y Leung; Keri B Vartanian; Susan L Stevens; Frances R Bahjat; Mary P Stenzel-Poore
Journal:  J Cereb Blood Flow Metab       Date:  2012-09-26       Impact factor: 6.200

7.  Unexpected Roles for Toll-Like Receptor 4 and TRIF in Intraocular Infection with Gram-Positive Bacteria.

Authors:  Salai Madhumathi Parkunan; C Blake Randall; Phillip S Coburn; Roger A Astley; Rachel L Staats; Michelle C Callegan
Journal:  Infect Immun       Date:  2015-07-20       Impact factor: 3.441

8.  Primed Mycobacterial Uveitis (PMU): Histologic and Cytokine Characterization of a Model of Uveitis in Rats.

Authors:  Kathryn L Pepple; Lauren Rotkis; Jennifer Van Grol; Leslie Wilson; Angela Sandt; Deborah L Lam; Eric Carlson; Russell N Van Gelder
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

9.  Role of toll-like receptors in human iris pigment epithelial cells and their response to pathogen-associated molecular patterns.

Authors:  Kelly Mai; Jeanie Jy Chui; Nick Di Girolamo; Peter J McCluskey; Denis Wakefield
Journal:  J Inflamm (Lond)       Date:  2014-07-16       Impact factor: 4.981

Review 10.  Macrophages and Uveitis in Experimental Animal Models.

Authors:  Salvador Mérida; Elena Palacios; Amparo Navea; Francisco Bosch-Morell
Journal:  Mediators Inflamm       Date:  2015-05-20       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.